Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
FRONTIERS IN ONCOLOGY（2022）
摘要
[This corrects the article DOI: 10.3389/fonc.2022.632042.].
更多查看译文
关键词
ASPM, gene expression, prognosis, tumor-infiltrating, biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要